BGLC (BioNexus Gene Lab) Tariff Resilience Score: 6/10 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGLC BioNexus Gene Lab Corp BGLC
58 GF Score
Price $1.68
GF Value $2.17
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is BioNexus Gene Lab Tariff Resilience Score?

BioNexus Gene Lab BGLC +4.67% 58 Tariff Resilience Score is 6 as of Jul. 16, 2026. GuruFocus rates BGLC with a GF Score™ of 58/100 and a GF Value™ of $2.17 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,617 Chemicals companies, BioNexus Gene Lab ranks better than 97.96% on this metric.

BioNexus Gene Lab has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

BioNexus Gene Lab has Biotech sector has some tariff exemptions, but reliance on imported lab equipment poses risks. Global sales and potential for alternative suppliers offer moderate resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes BioNexus Gene Lab might have Average Resilient.

BioNexus Gene Lab  (NAS:BGLC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

BioNexus Gene Lab Tariff Resilience Score Related Terms

BGLC vs QGAI, VYST, GLGI: Tariff Resilience Score Comparison

For the Specialty Chemicals subindustry, BioNexus Gene Lab's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNexus Gene Lab Tariff Resilience Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, BioNexus Gene Lab's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where BioNexus Gene Lab's Tariff Resilience Score falls into.


BGLC
58GF Score
BioNexus Gene Lab Corp BGLC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
BioNexus Gene Lab (BGLC) has a Tariff Resilience Score of 6 as of Jul. 16, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, BioNexus Gene Lab ranks #33 out of 1617 companies in the Chemicals industry, placing it in the top 2%.
Is BioNexus Gene Lab's Tariff Resilience Score too high?
BioNexus Gene Lab's current Tariff Resilience Score is 6. Based on the distribution chart, BioNexus Gene Lab ranks #33 out of 1617 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, BioNexus Gene Lab has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioNexus Gene Lab's Tariff Resilience Score compare to QGAI and VYST?
According to the Chemicals industry distribution chart, BioNexus Gene Lab ranks #33 out of 1617 companies for Tariff Resilience Score. This places BioNexus Gene Lab in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Chemicals company?
A good Tariff Resilience Score depends on the Chemicals industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. BioNexus Gene Lab's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNexus Gene Lab stock overvalued right now?
Based on GuruFocus' analysis, BioNexus Gene Lab (BGLC) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.17, compared to a current price of $1.68 — trading 22.6% below its estimated fair value. The current Tariff Resilience Score is 6. BioNexus Gene Lab's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For BioNexus Gene Lab (BGLC), the current Tariff Resilience Score is 6 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioNexus Gene Lab (BGLC) Overvalued in 2026?

Based on GuruFocus' analysis, BioNexus Gene Lab stock appears to be undervalued. The current stock price of $1.68 is trading 22.6% below its estimated GF Value™ of $2.17. GuruFocus considers BioNexus Gene Lab to be Modestly Undervalued.

Key valuation signals for BGLC:

  • Tariff Resilience Score: 6
  • GF Value™: $2.17 vs. price of $1.68 (22.6% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the BGLC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioNexus Gene Lab Business Description

Address No.5 Jln Bangsar Utama 1, Unit A-28-7, Level 28, Tower A, Menara UOA Bangsar, Kuala Lumpur, SGR, MYS, 59200
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
58GF Score

Get the complete analysis for BGLC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.68
Price
$2.17
GF Value